Temasek Holdings Private Ltd Buys New Position in GE HealthCare Technologies Inc. $GEHC

Temasek Holdings Private Ltd purchased a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the third quarter, Holdings Channel.com reports. The fund purchased 1,330,515 shares of the company’s stock, valued at approximately $99,922,000.

Other large investors have also added to or reduced their stakes in the company. Empowered Funds LLC increased its position in GE HealthCare Technologies by 6.1% during the 1st quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock valued at $2,328,000 after purchasing an additional 1,665 shares during the period. Acadian Asset Management LLC bought a new position in GE HealthCare Technologies in the 1st quarter worth $259,000. Campbell & CO Investment Adviser LLC purchased a new stake in shares of GE HealthCare Technologies in the 2nd quarter worth about $854,000. Vise Technologies Inc. purchased a new stake in shares of GE HealthCare Technologies in the 2nd quarter worth about $354,000. Finally, SBI Securities Co. Ltd. boosted its stake in shares of GE HealthCare Technologies by 8.2% during the 2nd quarter. SBI Securities Co. Ltd. now owns 5,147 shares of the company’s stock valued at $381,000 after purchasing an additional 391 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently issued reports on GEHC shares. Evercore boosted their price target on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. Wells Fargo & Company raised their price objective on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Citigroup lowered their price objective on shares of GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating for the company in a report on Wednesday. Piper Sandler lifted their price objective on GE HealthCare Technologies from $91.00 to $94.00 and gave the company an “overweight” rating in a research report on Friday, January 30th. Finally, BTIG Research upped their target price on GE HealthCare Technologies from $87.00 to $91.00 and gave the stock a “buy” rating in a report on Wednesday, February 4th. Seven analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, GE HealthCare Technologies has a consensus rating of “Hold” and an average price target of $92.17.

GE HealthCare Technologies Price Performance

Shares of GEHC opened at $70.77 on Friday. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $89.77. The firm’s 50-day simple moving average is $80.78 and its two-hundred day simple moving average is $78.48. The stock has a market cap of $32.25 billion, a PE ratio of 15.52, a price-to-earnings-growth ratio of 1.55 and a beta of 1.03. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.04. The firm had revenue of $5.70 billion during the quarter, compared to analyst estimates of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The business’s revenue was up 7.1% on a year-over-year basis. During the same period last year, the business earned $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be paid a dividend of $0.035 per share. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is presently 3.07%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.